CorMedix CRMD Unrealized Gains on Investments
Unrealized Gains on Investments at other companies
Other financials
Where this comes from
Reported directly by CorMedix in its filing.
Tagged under the XBRL concept us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax.
The official record: CorMedix’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about CorMedix's unrealized gains on investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is CorMedix's unrealized gains on investments?
- CorMedix (CRMD) reported unrealized gains on investments of $0 in Q4 2025.
- How has CorMedix's unrealized gains on investments changed year-over-year?
- CorMedix's unrealized gains on investments decreased by 100.0% year-over-year, from $4K to $0.
- What is the long-term trend for CorMedix's unrealized gains on investments?
- Over 3 years (2022 to 2025), CorMedix's unrealized gains on investments has grown at a -100.0% compound annual growth rate (CAGR), from $3.54K to $0.
- What does unrealized gains on investments mean?
- This represents the cumulative increase in the fair value of investment securities that have not yet been sold. It reflects the paper gains on the company's investment portfolio, which are typically recorded in accumulated other comprehensive income. Monitoring this provides insight into the performance of the company's treasury or investment strategy and potential future liquidity sources.